AA 是一种罕见的胃肠道癌症，发病率低，每 10 万人中约有 1.3 人发病，且属于罕见病范畴，目前尚无 FDA 批准的特效疗法。标准治疗方案为细胞减灭术联合腹腔热灌注化疗（CRS + HIPEC），但并非所有患者都适合手术。传统观念认为 AA 对全身化疗反应不佳，不过近年来，靶向治疗、免疫治疗和腹腔内定向治疗展现出一定潜力。

SPRINGFIELD, PA, UNITED STATES, February 1, 2025 /EINPresswire / -- In the fight against cancer, common types such as breast, lung, and colorectal of ...

Celebrated ESPN anchor Stuart Scott would have been 60 years old this year, and his former colleagues continue to mourn not ...

Henry Ford Health System in Detroit recently provided the first patient in Michigan — a 60-year-old man from the Cadillac ...

Rate of gene fusion/rearrangement identification in GI cancers as sequencing evolved from limited panels to whole exome sequencing. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

Surgical treatment in patients with advanced gastrointestinal stromal tumours (GISTs) in second-line and later stages: A single-centre cohort study. Evaluating the clinical benefits of anti-cancer ...

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.